HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

PHASE4CompletedINTERVENTIONAL

Enrollment

134,476

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Influenza

Interventions

DRUG

Influenza vaccine

Participants will be individually randomized 1:1 to receive either QIV-HD or QIV-SD, one dose, the day of the inclusion in the trial

Trial Locations (1)

General Public Health Directorate of Galician Health Service, Santiago de Compostela

All Listed Sponsors

lead

Federico Martinón Torres

OTHER

NCT06141655 - HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia | Biotech Hunter | Biotech Hunter